Yaspo lab / Publications

Huang, Y.; Mouttet , B.; Warnatz, H.-J.; Risch, T.; Rietmann, F.; Frommelt, F.; Ngo, Q. A.; Dobay, M. P.; Marovca, B.; Jenni, S. et al.; Tsai, Y.-C.; Matzk, S.; Amstislavskiy, V.; Schrappe, M.; Stanulla, M.; Gstaiger, M.; Bornhauser, B.; Yaspo, M.-L.; Bourquin , J.-P.: The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability. Cancer Cell 36 (6), pp. 630 - 644 (2019)

Schade, S.; Ogilvie, L. A.; Kessler, T.; Schütte, M.; Wierling, C.; Lange, B. M.; Lehrach, H.; Yaspo, M.-L.: A data- and model-driven approach for cancer treatment. Der Onkologe 25 (Suppl. 2), pp. S132 - S137 (2019)

Labuhn, M.; Perkins, K.; Matzk, S.; Varghese, L.; Garnett, C.; Papaemmanuil, E.; Metzner, M.; Kennedy, A.; Amstislavskiy, V.; Risch, T. et al.; Bhayadia, R.; Samulowski, D.; Hernandez, D. C.; Stoilova, B. ....; Yaspo, M.-L.; Campbell, P. J.; Roberts, I.; Constantinescu, S. N.; Vyas, P.; Heckl, D.; Klusmann, J.-H.: Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome. Cancer Cell 36 (2), pp. 123 - 138 (2019)

Schade, S.; Ogilvie, L. A.; Kessler, T.; Schütte, M.; Wierling, C.; Lange, B. M.; Lehrach, H.; Yaspo, M.-L.: Ein daten- und modellgesteuerter Ansatz zur Behandlung maligner Tumoren. Der Onkologe 25 (Suppl. 1), pp. S109 - S115 (2019)

Yi, G.; Wierenga, A. T. J.; Petraglia, F.; Narang, P.; Janssen-Megens, E. M.; Mandoli, A.; Merkel, A.; Berentsen, K.; Kim, B.; Matarese, F. et al.; Singh, A. A.; Habibi, E.; Prange, K. H. M.; Mulder, A. B.; Jansen, J. H.; Clarke, L.; Heath, S.; van der Reijden, B. A.; Flicek, P.; Yaspo, M.-L.; Gut, I.; Bock, C.; Schuringa, J. J.; Altucci, L.; Vellenga, E.; Stunnenberg, H. G.; Martens, J. H. A.: Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness Phenotypes. Cell Reports 26 (4), pp. 1059 - 1069 (2019)

Christensen, S.; Van der Roest, B.; Besselink, N.; Janssen, R.; Boymans, S.; Martens, J.; Yaspo, M.-L.; Priestley, P.; Kuijk, E.; Cuppen, E. et al.; Van Hoeck, A.: 5-Fluorouracil treatment induces characteristic T>G mutations in human cancer. Nature Communications 10, Article 4571, p. 1 (2019)